UniProt ID | TRIM3_HUMAN | |
---|---|---|
UniProt AC | O75382 | |
Protein Name | Tripartite motif-containing protein 3 | |
Gene Name | TRIM3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 744 | |
Subcellular Localization | Cytoplasm. Early endosome . Golgi apparatus, trans-Golgi network . Cell projection, dendrite . | |
Protein Description | Probably involved in vesicular trafficking via its association with the CART complex. [PubMed: 15772161 The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation] | |
Protein Sequence | MAKREDSPGPEVQPMDKQFLVCSICLDRYQCPKVLPCLHTFCERCLQNYIPAQSLTLSCPVCRQTSILPEQGVSALQNNFFISSLMEAMQQAPDGAHDPEDPHPLSVVAGRPLSCPNHEGKTMEFYCEACETAMCGECRAGEHREHGTVLLRDVVEQHKAALQRQLEAVRGRLPQLSAAIALVGGISQQLQERKAEALAQISAAFEDLEQALQQRKQALVSDLETICGAKQKVLQSQLDTLRQGQEHIGSSCSFAEQALRLGSAPEVLLVRKHMRERLAALAAQAFPERPHENAQLELVLEVDGLRRSVLNLGALLTTSATAHETVATGEGLRQALVGQPASLTVTTKDKDGRLVRTGSAELRAEITGPDGTRLPVPVVDHKNGTYELVYTARTEGELLLSVLLYGQPVRGSPFRVRALRPGDLPPSPDDVKRRVKSPGGPGSHVRQKAVRRPSSMYSTGGKRKDNPIEDELVFRVGSRGREKGEFTNLQGVSAASSGRIVVADSNNQCIQVFSNEGQFKFRFGVRGRSPGQLQRPTGVAVDTNGDIIVADYDNRWVSIFSPEGKFKTKIGAGRLMGPKGVAVDRNGHIIVVDNKSCCVFTFQPNGKLVGRFGGRGATDRHFAGPHFVAVNNKNEIVVTDFHNHSVKVYSADGEFLFKFGSHGEGNGQFNAPTGVAVDSNGNIIVADWGNSRIQVFDSSGSFLSYINTSAEPLYGPQGLALTSDGHVVVADAGNHCFKAYRYLQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAKREDSPG ------CCCCCCCCC | 21.44 | 19413330 | |
7 | Phosphorylation | -MAKREDSPGPEVQP -CCCCCCCCCCCCCC | 27.31 | 29255136 | |
23 | Phosphorylation | DKQFLVCSICLDRYQ CCCEEEEEHHHHHHC | 14.62 | 21406692 | |
159 | Ubiquitination | RDVVEQHKAALQRQL HHHHHHHHHHHHHHH | 34.74 | - | |
202 | Phosphorylation | AEALAQISAAFEDLE HHHHHHHHHHHHHHH | 11.06 | - | |
216 | Ubiquitination | EQALQQRKQALVSDL HHHHHHHHHHHHHHH | 35.27 | - | |
342 | Phosphorylation | ALVGQPASLTVTTKD HHCCCCCEEEEEEEC | 31.12 | 28857561 | |
344 | Phosphorylation | VGQPASLTVTTKDKD CCCCCEEEEEEECCC | 17.20 | 28857561 | |
346 | Phosphorylation | QPASLTVTTKDKDGR CCCEEEEEEECCCCC | 23.93 | 30177828 | |
347 | Phosphorylation | PASLTVTTKDKDGRL CCEEEEEEECCCCCE | 32.67 | 25690035 | |
357 | Phosphorylation | KDGRLVRTGSAELRA CCCCEEECCCCEEEE | 28.19 | 28348404 | |
359 | Phosphorylation | GRLVRTGSAELRAEI CCEEECCCCEEEEEE | 20.25 | 22964224 | |
412 | Phosphorylation | YGQPVRGSPFRVRAL HCCCCCCCCEEEEEC | 15.42 | 24719451 | |
427 | Phosphorylation | RPGDLPPSPDDVKRR CCCCCCCCHHHHHHH | 38.73 | 30266825 | |
437 | Phosphorylation | DVKRRVKSPGGPGSH HHHHHCCCCCCCCHH | 26.39 | 30266825 | |
443 | Phosphorylation | KSPGGPGSHVRQKAV CCCCCCCHHHHHHHH | 23.18 | 26055452 | |
454 | Phosphorylation | QKAVRRPSSMYSTGG HHHHCCCHHHCCCCC | 26.40 | 23882029 | |
455 | Phosphorylation | KAVRRPSSMYSTGGK HHHCCCHHHCCCCCC | 25.15 | 21712546 | |
457 | Phosphorylation | VRRPSSMYSTGGKRK HCCCHHHCCCCCCCC | 12.67 | 23403867 | |
458 | Phosphorylation | RRPSSMYSTGGKRKD CCCHHHCCCCCCCCC | 16.37 | 21712546 | |
459 | Phosphorylation | RPSSMYSTGGKRKDN CCHHHCCCCCCCCCC | 32.25 | 23403867 | |
483 | Ubiquitination | VGSRGREKGEFTNLQ ECCCCCCCCCCCCCC | 63.48 | - | |
487 | Phosphorylation | GREKGEFTNLQGVSA CCCCCCCCCCCCCCC | 30.62 | 22210691 | |
497 | Phosphorylation | QGVSAASSGRIVVAD CCCCCCCCCCEEEEC | 27.62 | 22210691 | |
529 | Phosphorylation | RFGVRGRSPGQLQRP EEECCCCCCCCCCCC | 35.88 | 24719451 | |
537 | Phosphorylation | PGQLQRPTGVAVDTN CCCCCCCCEEEECCC | 46.61 | 28102081 | |
579 | Ubiquitination | AGRLMGPKGVAVDRN CCCCCCCCEEEECCC | 61.36 | - | |
615 | Methylation | LVGRFGGRGATDRHF EEEEECCCCCCCCCC | 31.77 | 115918957 | |
639 | Phosphorylation | NKNEIVVTDFHNHSV CCCCEEEEECCCCEE | 23.27 | - | |
649 | Phosphorylation | HNHSVKVYSADGEFL CCCEEEEEECCCCEE | 7.76 | 23403867 | |
650 | Phosphorylation | NHSVKVYSADGEFLF CCEEEEEECCCCEEE | 23.91 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRIM3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRIM3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRIM3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRIM3_HUMAN | TRIM3 | physical | 11331580 | |
ACTN4_HUMAN | ACTN4 | physical | 10673389 | |
UB2D4_HUMAN | UBE2D4 | physical | 21143188 | |
ACTN4_HUMAN | ACTN4 | physical | 15772161 | |
MYO5A_HUMAN | MYO5A | physical | 15772161 | |
ODPA_HUMAN | PDHA1 | physical | 26344197 | |
CDN1A_HUMAN | CDKN1A | physical | 24393003 | |
UB2D1_HUMAN | UBE2D1 | physical | 24393003 | |
UB2D2_HUMAN | UBE2D2 | physical | 24393003 | |
UB2E1_HUMAN | UBE2E1 | physical | 24393003 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-7, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437, AND MASSSPECTROMETRY. |